Company Announcement no. 3/2011
To: NASDAQ OMX Copenhagen A/S Hørsholm, Denmark, March 17, 2011
Member of the Board of Directors has passed away
LifeCycle Pharma A/S (OMX: LCP) today announced with great sadness that Dr. Jean Deleage, member of the Board of Directors of LCP, has passed away following a short period of severe illness.
Jean Deleage has been a member of the Board of Directors of LCP since 2005 and has during this period been a significant contributor to the development of the Company.
Jean began his venture capital career with Sofinnova in 1971 in Paris, France. Jean was a visionary industry leader within biotechnology, and in 1996 he co-founded the Alta BioPharma family of funds, one of the very first venture capital initiatives to fund later stage life sciences companies. Jean was an early investor in many of the leading companies in the field today, including Cephalon, Chiron and Genentech.
We honor his memory.
For further information, please contact:
|
LifeCycle Pharma A/S William J. Polvino, President and CEO Mobile: +1 (917) 647 9107 Email: WJP@lcpharma.com |
|
